IL6 and neoplasm: A similar TLR2/4-STAT3 response driven by HSPs was seen in bone marrow-derived dendritic cells (BMDCs) promoting a pro-tumor IL-6, PGE-2, IL-1, and TNF response after exosome treatment (68).